-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Arcus Biosciences, Raises Price Target to $32

Benzinga·12/12/2025 16:49:02
語音播報
HC Wainwright & Co. analyst Emily Bodnar maintains Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $28 to $32.